COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M. Johannessen, Levi A. Garraway, Leslie Wardwell et al.|Nature|2010Cited by 1.4k
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent <i>in vivo</i> antitumor activitySauveur-Michel Maira, Carlos García-Echeverría, Frédéric Stauffer et al.|Molecular Cancer Therapeutics|2008Cited by 1.1k